72-785

Tocris Bioscience™ a1A-AR Degrader 9c

Manufacturer: Tocris Bioscience™

Select a Size

Pack Size SKU Availability Price
Each of 1 72-785-Each-of-1 In Stock ₹ 40,272.50

72-785 - Each of 1

₹ 40,272.50

In Stock

Quantity

1

Base Price: ₹ 40,272.50

GST (18%): ₹ 7,249.05

Total Price: ₹ 47,521.55

Chemical Name or Material

2-(2-(2-(2-(4-(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carbonyl)-1 H-1,2,3-triazol-1-yl)ethoxy)ethoxy)ethoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)acetamide

Target

Active Degraders

Purity

0.98

Quantity

5 mg

Molecular Formula

C38H43N11O11

Related Products

Img

Tocris Bioscience™

73-965

--

Img

Tocris Bioscience™

75-885

--

Img

Tocris Bioscience™

75-305

--

Img

Tocris Bioscience™

72-401

--

Img

Tocris Bioscience™

73-195

--

Img

Tocris Bioscience™

75-755

--

Img

Tocris Bioscience™

73-975

--

Img

Tocris Bioscience™

75-045

--

Description

  • α1A-AR Degrader 9c is a selective α1A-adrenergic receptor Degrader (PROTAC®; DC50 = 2.86 μM, 94% α1A-adrenoceptor degradation at 10 μM for 12 h)
  • It comprises the α-adrenoceptor antagonist Prazosin (Cat
  • No
  • 0623), joined by a linker to a cereblon ligand Pomalidomide (Cat
  • No
  • 6302)
  • α1A-AR Degrader 9c selectively downregulates α1A-adrenoceptor levels, but not α1B-AR and α1D-AR in HEK293 cells
  • α1A-AR Degrader 9c shows concentration-dependent antiproliferative activity in PC-3 prostate cancer cells (IC50 = 6.12 μM) in vitro , and PC-3 tumor xenografts in vivo
  • PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license .

SAFETY INFORMATION

  • Recommended Storage : Store at -20°C